{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:05:03Z","timestamp":1784811903066,"version":"3.55.0"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Chemoresistance remains a major obstacle to effective treatment and durable remission in leukemia patients. Although initial responses to chemotherapy are often favorable, relapse frequently occurs due to the emergence of drug-resistant malignant clones. Resistance mechanisms may be intrinsic or acquired and involve drug efflux, impaired apoptosis, enhanced DNA repair, epigenetic alterations, dysregulated signaling pathways, and microenvironmental interactions. A central mediator of multidrug resistance is the ATP-binding cassette (ABC) transporter family, particularly ABCB1 (also known as P-glycoprotein or MDR-1), which actively exports chemotherapeutic agents such as etoposide, doxorubicin, and vincristine, thereby reducing intracellular drug accumulation. Adult T-cell Leukemia\/Lymphoma (ATLL), an aggressive malignancy caused by Human T-cell Leukemia Virus type 1 (HTLV-1), is characterized by poor prognosis and marked resistance to chemotherapy. Despite the recent approval of novel therapeutic agents, treatment outcomes remain unsatisfactory, largely due to both inherent and acquired chemoresistance. Overexpression of ABCB1 has been identified as a key mechanism contributing to multidrug resistance in ATLL. We compared the expression profiles of ABC transporter genes in CD8\u207a-depleted peripheral blood mononuclear cells (PBMCs) from HTLV-1 asymptomatic carriers and patients with acute ATLL. To investigate the role of the viral transactivator Tax in regulating ABCB1 expression, we used HuT78 and JPX9 T-cell lines. Furthermore, Tax expression was reactivated in CD8\u207a-depleted PBMCs from acute ATLL patients using valproic acid, and subsequent changes in ABCB1 expression and chemosensitivity to etoposide and doxorubicin were assessed. We found that ABCB1 expression was significantly upregulated in CD8\u207a-depleted PBMCs from patients with acute ATLL compared to asymptomatic HTLV-1 carriers. In contrast, expression of the viral protein Tax in HuT78 and JPX9 cell lines resulted in decreased ABCB1 levels. Reactivation of Tax expression using valproic acid in primary ATLL samples confirmed that Tax downregulates ABCB1 expression. Importantly, Tax reactivation restored sensitivity of ATLL cells to chemotherapeutic agents, including etoposide and doxorubicin. Our findings identify ABCB1 overexpression as a major contributor to chemoresistance in acute ATLL and demonstrate that the viral protein Tax negatively regulates ABCB1 expression. These results suggest that reactivation of Tax may reduce drug efflux capacity and restore chemosensitivity in resistant ATLL cells. Collectively, this study provides a rationale for exploring a \u201cTax-based shock-andkill\u201d strategy as a potential therapeutic approach to overcome chemoresistance in ATLL.<\/jats:p>","DOI":"10.3389\/fonc.2026.1721313","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:48:34Z","timestamp":1773298114000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Valproate reactivates HTLV-1 tax and reduces ABCB1\/MDR1 expression in PBMCs derived from ATLL patients"],"prefix":"10.3389","volume":"16","author":[{"given":"C\u00e9lima","family":"Mourouvin","sequence":"first","affiliation":[{"name":"Universit\u00e9 Montpellier (UM)","place":["Montpellier, France"]},{"name":"Institut de Recherche en Infectiologie de Montpellier (IRIM), Centre National de la Recherche Scientifique (CNRS)","place":["Montpellier, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Tram","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Montpellier (UM)","place":["Montpellier, France"]},{"name":"Institut de Recherche en Infectiologie de Montpellier (IRIM), Centre National de la Recherche Scientifique (CNRS)","place":["Montpellier, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Marty","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Montpellier (UM)","place":["Montpellier, France"]},{"name":"Institut de Recherche en Infectiologie de Montpellier (IRIM), Centre National de la Recherche Scientifique (CNRS)","place":["Montpellier, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika","family":"Marie-Delcasse","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Montpellier (UM)","place":["Montpellier, France"]},{"name":"Institut de Recherche en Infectiologie de Montpellier (IRIM), Centre National de la Recherche Scientifique (CNRS)","place":["Montpellier, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gildas","family":"Belrose","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire de Martinique","place":["Fort-de-France, Martinique"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta","family":"Pluta","sequence":"additional","affiliation":[{"name":"Department of Virology and Viral Animal Diseases, National Veterinary Research Institute","place":["Pu\u0142awy, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"C\u00e9saire","sequence":"additional","affiliation":[{"name":"Centre Hospitalier Universitaire de Martinique","place":["Fort-de-France, Martinique"]},{"name":"D\u00e9partement de Radioth\u00e9rapie-Oncologie-H\u00e9matologie, Centre Hospitalier Universitaire de La Guadeloupe","place":["Pointe-\u00e0-Pitre, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillipe","family":"H\u00e9lias","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Radioth\u00e9rapie-Oncologie-H\u00e9matologie, Centre Hospitalier Universitaire de La Guadeloupe","place":["Pointe-\u00e0-Pitre, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Baccini","sequence":"additional","affiliation":[{"name":"Laboratoire d\u2019H\u00e9matologie Centre Hospitalier Universitaire (CHU) de la Guadeloupe Pointe \u00e0 Pitre Guadeloupe","place":["Pointe-\u00e0-Pitre, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Jean-Marie","family":"Peloponese","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Montpellier (UM)","place":["Montpellier, France"]},{"name":"Institut de Recherche en Infectiologie de Montpellier (IRIM), Centre National de la Recherche Scientifique (CNRS)","place":["Montpellier, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.blre.2015.08.001","article-title":"Role of drug transport and metabolism in the chemoresistance of acute myeloid leukemia","volume":"30","author":"Marin","year":"2016","journal-title":"Blood Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcdb.2017.07.019","article-title":"Autocrine mechanisms of cancer chemoresistance","volume":"78","author":"Butera","year":"2018","journal-title":"Semin Cell Dev Biol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19048","article-title":"The molecular mechanisms of chemoresistance in cancers","volume":"8","author":"Zheng","year":"2017","journal-title":"Oncotarget"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2174\/138161206775201965","article-title":"An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy","volume":"12","author":"Takara","year":"2006","journal-title":"Curr Pharm Des"},{"key":"B5","doi-asserted-by":"publisher","first-page":"9451","DOI":"10.3390\/ijms22179451","article-title":"Battling chemoresistance in cancer: root causes and strategies to uproot them","volume":"22","author":"Ramos","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological aspects and world distribution of HTLV-1 infection","volume":"3","author":"Gessain","year":"2012","journal-title":"Front Microbiol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001628","article-title":"Adult T-cell leukemia\/lymphoma incidence rate in French Guiana: a prospective cohort of women infected with HTLV-1","volume":"4","author":"Ramassamy","year":"2020","journal-title":"Blood Adv"},{"key":"B8","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3390\/v17050664","article-title":"Human T-lymphotropic virus (HTLV): epidemiology, genetic, pathogenesis, and future challenges","volume":"17","author":"Branda","year":"2025","journal-title":"Viruses"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1051\/medsci\/2010264391","article-title":"Adult T-cell leukemia induced by HTLV-1: before and after HBZ","volume":"26","author":"Duc Dodon","year":"2010","journal-title":"Med Sci Paris"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605345","article-title":"Mechanisms of HTLV-1 persistence and transformation","volume":"101","author":"Boxus","year":"2009","journal-title":"Br J Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"213653","DOI":"10.1155\/2012\/213653","article-title":"Molecular and cellular mechanism of leukemogenesis of ATL: emergent evidence of a significant role for HBZ in HTLV-1-induced pathogenesis","volume":"2012","author":"Satou","year":"2012","journal-title":"Leuk Res Treat"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-321364","article-title":"Effects of valproate on Tax and HBZ expression in HTLV-1 and HAM\/TSP T lymphocytes","volume":"118","author":"Belrose","year":"2011","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.24.12813-12822.2002","article-title":"The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription","volume":"76","author":"Gaudray","year":"2002","journal-title":"J Virol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0010807","DOI":"10.1371\/journal.pntd.0010807","article-title":"The importance of the clinical classification of adult T-cell leukemia\/lymphoma (ATLL) in the prognosis","volume":"16","author":"Oliveira","year":"2022","journal-title":"PloS Negl Trop Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/v7122952","article-title":"Roles of HTLV-1 basic zip factor (HBZ) in viral chronicity and leukemic transformation. Potential new therapeutic approaches to prevent and treat HTLV-1-related diseases","volume":"7","author":"Mesnard","year":"2015","journal-title":"Viruses"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.537","article-title":"Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy","volume":"30","author":"Matsuoka","year":"2010","journal-title":"Oncogene"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002038","article-title":"Rapid progression of adult T-cell leukemia\/lymphoma as tumor-infiltrating Tregs after PD-1 blockade","volume":"134","author":"Rauch","year":"2019","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-4615-1601-9_3","article-title":"HTLV-I associated leukemia\/lymphoma: epidemiology, biology, and treatment","volume":"104","author":"Siegel","year":"2001","journal-title":"Cancer Treat Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199606010-00012","article-title":"An intensive chemotherapy of adult T-cell leukemia\/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support","volume":"12","author":"Taguchi","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.21037\/sci.2016.09.13","article-title":"Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia\/lymphoma","volume":"3","author":"Fuji","year":"2016","journal-title":"Stem Cell Investig"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/2.suppl_2.151","article-title":"Expression of growth-related genes and drug-resistance genes in HTLV-I-positive and HTLV-I-negative post-thymic T-cell Malignancies","volume":"2","author":"Su","year":"1991","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.7.2480","article-title":"Possible roles of an adult T-cell leukemia (ATL)-derived factor\/thioredoxin in the drug resistance of ATL to adriamycin","volume":"89","author":"Wang","year":"1997","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V91.7.2467","article-title":"Enhanced MDR1 gene expression in human T-cell leukemia virus-I-infected patients offers new prospects for therapy","volume":"91","author":"Lau","year":"1998","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.54.1953","article-title":"Clinical Features and Treatment Outcomes of 81 Patients with Aggressive Type Adult T-cell Leukemia-lymphoma at a Single Institution over a 7-year Period (2006-2012)","volume":"54","author":"Kawano","year":"2015","journal-title":"Intern Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"114542","DOI":"10.1016\/j.ejmech.2022.114542","article-title":"Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update","volume":"239","author":"Engle","year":"2022","journal-title":"Eur J Med Chem"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-018-0005-8","article-title":"Revisiting the role of ABC transporters in multidrug-resistant cancer","volume":"18","author":"Robey","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2007.00538.x","article-title":"Mechanism of multidrug recognition by MDR1\/ABCB1","volume":"98","author":"Kimura","year":"2007","journal-title":"Cancer Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"108488","DOI":"10.1016\/j.pharmthera.2023.108488","article-title":"Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): An updated review","volume":"249","author":"Dong","year":"2023","journal-title":"Pharmacol Ther"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3892\/or.2015.4536","article-title":"HIF-1\u03b1\/MDR1 pathway confers chemoresistance to cisplatin in bladder cancer","volume":"35","author":"Sun","year":"2016","journal-title":"Oncol Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30137","article-title":"A novel EGR-1 dependent mechanism for YB-1 modulation of paclitaxel response in a triple negative breast cancer cell line","volume":"139","author":"Lasham","year":"2016","journal-title":"Int J Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.biopha.2013.01.001","article-title":"Egr-1 enhances drug resistance of breast cancer by modulating MDR1 expression in a GGPPS-independent manner","volume":"67","author":"Tao","year":"2013","journal-title":"Biomed Pharmacother Biomed Pharmacother"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2015.11.013","article-title":"Chemotherapy induces stemness in osteosarcoma cells through activation of Wnt\/\u03b2-catenin signaling","volume":"370","author":"Martins-Neves","year":"2016","journal-title":"Cancer Lett"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-161729","article-title":"Human T-cell leukemia virus type 1 bZIP factor selectively suppresses the classical pathway of NF-kappaB","volume":"113","author":"Zhao","year":"2009","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01824-08","article-title":"Peptidylproline cis-trans-isomerase Pin1 interacts with human T-cell leukemia virus type 1 tax and modulates its activation of NF-kappaB","volume":"83","author":"Peloponese","year":"2009","journal-title":"J Virol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.74","article-title":"HBZ-mediated shift of JunD from growth suppressor to tumor promoter in leukemic cells by inhibition of ribosomal protein S25 expression","volume":"31","author":"Terol","year":"2017","journal-title":"Leukemia"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3109\/00498254.2011.587033","article-title":"Calcein assay: a high-throughput method to assess P-gp inhibition. Xenobiotica Fate Foreign Compd","volume":"41","author":"Glavinas","year":"2011","journal-title":"Biol Syst"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00661-12","article-title":"Human T-cell leukemia virus type 1 (HTLV-1) bZIP factor requires cellular transcription factor JunD to upregulate HTLV-1 antisense transcription from the 3\u2019 long terminal repeat","volume":"86","author":"Gazon","year":"2012","journal-title":"J Virol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"101754","DOI":"10.1155\/2012\/101754","article-title":"Clinical trials and treatment of ATL","volume":"2012","author":"Tsukasaki","year":"2012","journal-title":"Leuk Res Treat"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199304083281404","article-title":"Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin\u2019s lymphoma","volume":"328","author":"Fisher","year":"1993","journal-title":"N Engl J Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1248\/yakushi.22-00108","article-title":"Role of ABC transporters in cancer development and Malignant alteration","volume":"142","author":"Wada","year":"2022","journal-title":"Yakugaku Zasshi"},{"key":"B42","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.110.036160","article-title":"Endoxifen, the active metabolite of tamoxifen, is a substrate of the efflux transporter P-glycoprotein (multidrug resistance 1). Drug Metab. Dispos","volume":"39","author":"Teft","year":"2011","journal-title":"Biol Fate Chem"},{"key":"B44","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2174\/1874467210801020093","article-title":"Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: Evaluation of current strategies","volume":"1","author":"Wu","year":"2008","journal-title":"Curr Mol Pharmacol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.120.000025","article-title":"ABCB1 and ABCG2 regulation at the blood-brain barrier: potential new targets to improve brain drug delivery","volume":"75","author":"Schulz","year":"2023","journal-title":"Pharmacol Rev"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/pro.5155","article-title":"Mutational analysis reveals the importance of residues of the access tunnel inhibitor site to human P-glycoprotein (ABCB1)-mediated transport","volume":"33","author":"Salazar","year":"2024","journal-title":"Protein Sci Publ Protein Soc"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.7326","article-title":"Tax of the human T-lymphotropic virus type I transactivates promoter of the MDR-1 gene","volume":"238","author":"Chuang","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110295200","article-title":"Prevalent loss of mitotic spindle checkpoint in adult T-cell leukemia confers resistance to microtubule inhibitors","volume":"277","author":"Kasai","year":"2002","journal-title":"J Biol Chem"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1532\/IJH97.07087","article-title":"Human T-cell leukemia virus type 1 Tax and cellular transformation","volume":"86","author":"Peloponese","year":"2007","journal-title":"Int J Hematol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgn092","article-title":"Role of FoxO1 activation in MDR1 expression in adriamycin-resistant breast cancer cells","volume":"29","author":"Han","year":"2008","journal-title":"Carcinogenesis"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-07-0397","article-title":"Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells","volume":"7","author":"Hui","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00036-11","article-title":"The human T-cell leukemia virus type 1 oncoprotein tax controls forkhead box O4 activity through degradation by the proteasome","volume":"85","author":"Oteiza","year":"2011","journal-title":"J Virol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.2217\/fvl.11.94","article-title":"Outfoxing FoxO transcription factors: HTLV-1 Tax oncoprotein inactivates FoxO4 via the ubiquitin-proteasome pathway","volume":"6","author":"Shembade","year":"2011","journal-title":"Future Virol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.038984","article-title":"Chemical interrogation of FOXO3a nuclear translocation identifies potent and selective inhibitors of phosphoinositide 3-kinases","volume":"284","author":"Link","year":"2009","journal-title":"J Biol Chem"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00338.2013","article-title":"Mathematical modeling reveals modulation of both nuclear influx and efflux of Foxo1 by the IGF-I\/PI3K\/Akt pathway in skeletal muscle fibers","volume":"306","author":"Wimmer","year":"2014","journal-title":"Am J Physiol Cell Physiol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.241","article-title":"Augmented efficacy with the combination of blockade of the Notch-1 pathway, bortezomib and romidepsin in a murine MT-1 adult T-cell leukemia model","volume":"29","author":"Yu","year":"2015","journal-title":"Leukemia"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2007.05.026","article-title":"Histone deacetylase inhibitors induce growth arrest and apoptosis of HTLV-1-infected T-cells via blockade of signaling by nuclear factor kappaB","volume":"32","author":"Nishioka","year":"2008","journal-title":"Leuk Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/med.10017","article-title":"Anti-tumor mechanisms of valproate: a novel role for an old drug","volume":"22","author":"Blaheta","year":"2002","journal-title":"Med Res Rev"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2007.06.014","article-title":"Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response","volume":"35","author":"Lagneaux","year":"2007","journal-title":"Exp Hematol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21132","article-title":"Increase in platelet count in older, poor-risk patients with acute myeloid leukemia or myelodysplastic syndrome treated with valproic acid and all-trans retinoic acid","volume":"104","author":"Pilatrino","year":"2005","journal-title":"Cancer"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2011.07.015","article-title":"Efficacy of novel histone deacetylase inhibitor, AR42, in a mouse model of, human T-lymphotropic virus type 1 adult T cell lymphoma","volume":"35","author":"Zimmerman","year":"2011","journal-title":"Leuk Res"},{"key":"B62","doi-asserted-by":"publisher","first-page":"107057","DOI":"10.1016\/j.ejps.2025.107057","article-title":"Clinical efficacy and mechanistic insights of FDA-approved HDAC inhibitors in the treatment of lymphoma","volume":"208","author":"El Omari","year":"2025","journal-title":"Eur J Pharm Sci"},{"key":"B63","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s12032-022-01833-6","article-title":"Phase II study of sodium valproate in combination with oral etoposide in platinum-resistant ovarian cancer","volume":"39","author":"Nakka","year":"2022","journal-title":"Med Oncol Northwood Lond Engl"},{"key":"B64","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s13063-021-05373-8","article-title":"SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol","volume":"22","author":"McCarthy","year":"2021","journal-title":"Trials"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1172\/JCI69738","article-title":"New and emerging HDAC inhibitors for cancer treatment","volume":"124","author":"West","year":"2014","journal-title":"J Clin Invest"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000001746","article-title":"Effect of valproic acid and levetiracetam administration on the survival of glioma patients: a meta-analysis study","volume":"36","author":"Shirani","year":"2025","journal-title":"Anticancer Drugs"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-04-085076","article-title":"Histone deacetylase mediated transcriptional activation reduces proviral loads in HTLV-1 associated myelopathy\/tropical spastic paraparesis patients","volume":"110","author":"Lezin","year":"2007","journal-title":"Blood"},{"key":"B68","doi-asserted-by":"publisher","first-page":"4877","DOI":"10.1182\/blood.V120.21.4877.4877","article-title":"The combination of AZT\/interferon-\u03b1 Therapy with the HDAC inhibitor valproic acid for the treatment of adult T-cell leukemia\/lymphoma","volume":"120","author":"Reis","year":"2012","journal-title":"Blood"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3390\/genes14061295","article-title":"Histone deacetylases (HDAC) inhibitor\u2014Valproic acid sensitizes human melanoma cells to dacarbazine and PARP inhibitor","volume":"14","author":"Drzewiecka","year":"2023","journal-title":"Genes"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2007.00361.x","article-title":"Chronic treatment of rats with sodium valproate downregulates frontal cortex NF-kappaB DNA binding activity and COX-2 mRNA","volume":"9","author":"Rao","year":"2007","journal-title":"Bipolar Disord"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(99)02439-7","article-title":"Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB","volume":"857","author":"Ichiyama","year":"2000","journal-title":"Brain Res"},{"key":"B72","doi-asserted-by":"publisher","first-page":"106392","DOI":"10.1016\/j.intimp.2020.106392","article-title":"Sodium valproate attenuates the iE-DAP induced inflammatory response by inhibiting the NOD1-NF-\u03baB pathway and histone modifications in bovine mammary epithelial cells","volume":"83","author":"Gao","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"16457","DOI":"10.1038\/s41598-018-34915-5","article-title":"Valproate reduces neuroinflammation and neuronal death in a rat chronic constriction injury model","volume":"8","author":"Chen","year":"2018","journal-title":"Sci Rep"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.4161\/cc.7.14.6268","article-title":"A novel effect of DNA methyltransferase and histone deacetylase inhibitors: NFkappaB inhibition in Malignant myeloblasts","volume":"7","author":"Fabre","year":"2008","journal-title":"Cell Cycle Georget Tex"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1367043","article-title":"Valproic acid downregulates NF-\u03baB p50 activity and IRAK-1 in a progressive thyroid carcinoma cell line","volume":"46","author":"Schwertheim","year":"2014","journal-title":"Horm Metab Res Horm Stoffwechselforschung Horm Metab"},{"key":"B76","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.fct.2014.08.009","article-title":"Role of Nrf2 activation and NF-\u03baB inhibition in valproic acid induced hepatotoxicity and in diammonium glycyrrhizinate induced protection in mice","volume":"73","author":"Jin","year":"2014","journal-title":"Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1721313\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:48:36Z","timestamp":1773298116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1721313\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":76,"alternative-id":["10.3389\/fonc.2026.1721313"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1721313","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"article-number":"1721313"}}